FindTrial
Sign In

Inhaled corticosteroid as a risk of glaucoma: systematic review and meta-analysis

Inhaled corticosteroid as a risk of glaucoma: systematic review and meta-analysis - Inhaled corticosteroid as a risk of glaucoma: systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040351
Enrollment
Unknown
Registered
2020-05-10
Start date
2020-05-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Sponsors

Yokohama City University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In a case-control studies, cases should have glaucoma. Glaucoma need not be specified as open-angle, closed-angle, or normal-tension glaucoma. In a cohort study and an RCT, ICS-treated patients with any respiratory diseases including asthma and ACO may be included. No limitation was set for dosage, frequency, or timing of ICS-treatment.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The primary outcome was glaucoma frequency in the form of an unadjusted odds ratio (OR) between ICS and non-ICS population.—

Countries

Japan

Contacts

Public ContactNobuyuki Horita

Yokohama City University School of Medicine Department of Pulmonology

horitano@yokohama-cu.ac.jp0457872800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026